×
The Standard e-Paper
Join Thousands of Readers
The Standard Group Plc is a
multi-media organization with investments in media platforms spanning newspaper
print operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a leading multi-media house in Kenya with a key
influence in matters of national and international interest.
Kenya is one of two African countries that have started clinical trials for a drug that might be the cure to coronavirus that has caused thousands of deaths globally in addition to an economic meltdown.
The study whose results are expected in three months’ time will evaluate the efficacy and safety of Roche’s medicine Actemra (tocilizumab) in the treatment of Covid-19 associated pneumonia in hospitalised patients was initiated by Genentech, a member of the Roche Group, in the United States in May 2020. The trial has now expanded to other sites in South Africa, Kenya, Brazil, Mexico and Peru.
Subscribe to our newsletter and stay updated on the latest developments and special offers!
join